Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
32-33
|
pubmed:dateCreated |
1990-10-16
|
pubmed:language |
swe
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0023-7205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2514
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
1990
|
pubmed:articleTitle |
[Be restrictive in the use of quinolone treatment of gonorrhea--the risk of resistance].
|
pubmed:affiliation |
Kliniskt mikrobiologiska laboratoriet, Huddinge, sjukhus.
|
pubmed:publicationType |
Journal Article,
Case Reports
|